Why are a growing number of young people who are NEET reporting work-limiting health conditions? - The Health Foundation

The publication of this infographic was funded by Vertex Pharmaceuticals. Medical writing assistance was provided by Bethany Cooper, Ownership Health Limited, UK. Advances in cystic fibrosis care have transformed expectations for many people living with the disease. Evidence continues to support intervening early to prevent irreversible organ damage and optimise outcomes.

Case: In a patient diagnosed with metastatic clear cell RCC, foci observed at very low levels on 18F-FDG PET/CT, and some that were not detectable at all, were seen as dramatically dense on [68Ga]Ga-DPI-4452-PET/CT (carbonic anhydrase IX receptor) imaging. Image courtesy of Prof. Arslan Research was presented at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM’26)

AcknowledgementsThe authors thank Arcus Biosciences for providing AB680 and AB928 for the experiments. This research was supported [in part] by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, CCR, CIL. The contributions of the NIH authors (S. T., C. I. K. C., F. J. G.) were made as part of their official duties as NIH federal employees, are in compliance with agency policy requirements, and are considered Works of the United States Government. However, the findings and conclusions presented in this paper are those of the authors and do not necessarily reflect the views of the NIH or the U. S. Department of Health and Human Services. Schematic diagrams (Figs. 1A, E, 2A, E, 5D, 6A, D and 7A, G) were created with BioRender.com. FundingThis work was funded by NIH grants R01CA148828, R01CA245546, R01DK095201, and UMCCC Core Grant P30CA046592 (Y. M. S.). R01AI152517 to C. A. P. R01CA248160 to C. A. L. R. S. was supported by a Postdoctoral Fellowship (032650) from the American Physiological Society and a Research Fellow Award (1003279) from the Crohn’s and Colitis Foundation. N. W. Z.

RSV IN lung transplant recipients was associated with respiratory failure, declining lung function, and mortality in hospitalized patients. An international multicenter study of 155 adult lung transplant recipients hospitalized with respiratory syncytial virus (RSV) infection identified clinical predictors of severe complications, highlighting the importance of early assessment and continued monitoring in this vulnerable population.